Radiopharmaceuticals Market Global Scenario, Market Size, Outlook, Trend and Forecast, 2015 – 2024 Radiopharmaceutical is a radioactive pharmaceutical agent which is used diagnostic or therapeutic procedures. A radiopharmaceutical is made up of two components that are drug component and radioactive component. This radioactive component consists of radioisotopes which emits gamma rays which help in diagnostic. Moreover, these radioisotopes emit short range particles which lose their power in short distance which causes a lot of cell destruction. Radiopharmaceutical have been used effectively for cancer cell destruction, pain treatment in palliative care for bone cancer or arthritis. Browse
Complete
Report
@
https://www.variantmarketresearch.com/report-
categories/pharmaceuticals/radiopharmaceuticals-market
Get Sample Copy of This Report @ http://bit.ly/2rlk8ib The growth of global radiopharmaceutical market is attributed to the factors such as increase in the number of patients of cancer, dementia and Alzhimer’s Parkinson and increase in demand
Variant Market Research
from developing countries attributed to non-invasiveness procedures. Moreover, factors such as advances in radiotracers is also fueling the growth of global radiopharmaceutical market. However, side effects due to consumption of high doses and stringent regulatory guidelines restraints the growth of market. The global radiopharmaceuticals market is segmented on the basis of product type, application and geography. On the basis on product type the market is segmented into diagnostic and therapeutic products. Diagnostic products market is further classified into SPECT and PET isotopes. Therapeutics market segment is further classified alpha emitters, beta emitters, and brachytherapy. On the basis of application market is segmented into cardiology, neurology, oncology, thyroid, bone metastasis, and endocrine tumors. Geographic breakdown and deep analysis of each of the aforesaid segments is included for North America, Europe, Asia-Pacific, and rest of the world (RoW). Some of the major companies in global radiopharmaceuticals market are Cardinal Health, Inc., GE Healthcare, Eczacibasi-Monrol Nuclear Products, Bayer Healthcare AG, IBA Molecular Imaging, Mallinckrodt plc., Sigma Aldrich Corporation, Medtronic plc, Nordien, Inc., Jubilant Pharma, and Siemens Healthcare. Scope of Radiopharmaceuticals Market Product Type Segments •
•
Diagnostic o
SPECT
o
PET isotopes
Therapeutic o
Classified alpha emitters
o
Beta emitters
o
Brachytherapy
Application Segments •
Cardiology
•
Neurology
•
Oncology
Variant Market Research
•
Thyroid
•
Bone metastasis
•
Endocrine tumors
Geographical Segments •
•
•
•
North America o
US
o
Canada
o
Mexico
Europe o
Germany
o
France
o
United Kingdom
o
Spain
o
Others
Asia-Pacific o
China
o
India
o
Japan
o
South Korea
o
Others
RoW o
South America
o
Middle East
o
Africa
Contact Us: VARIANT MARKET RESEARCH LLP Web: https://www.variantmarketresearch.com/ USA Office: 649 Mission St., 5th Floor, San Francisco, CA 94105, United States.
Variant Market Research
Tel: +1-415-680-2785 Fax: +1-415-680-2786 Email: help@variantmarketresearch.com India Office (Corporate Headquarter): Office No. FL No.7, Prakash Developers, Survey no 34/A5, Wadgaon Sheri, Nagar Road, Pune – 411014 Tel: +91 20 6533779
Variant Market Research